Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Agonist Treatment”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT04109118
What this trial is testing

Benzodiazepine Discontinuation in Opioid Agonist Therapy

Who this might be right for
Substance Use Disorders
Boston Medical Center 4
Large-scale testing (Phase 3)Study completedNCT00497068
What this trial is testing

Tobacco Use in Opioid Agonist Treated Pregnant Women

Who this might be right for
Nicotine Dependence
Johns Hopkins University 210
Testing effectiveness (Phase 2)Study completedNCT01895036
What this trial is testing

Nalrexone Facilitated Discontinuation of Buprenorphine

Who this might be right for
Stable Opioid Dependence
New York State Psychiatric Institute 6
Large-scale testing (Phase 3)Looking for participantsNCT03646058
What this trial is testing

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Who this might be right for
Suicidal IdeationMajor Depressive Episode
Centre Hospitalier Universitaire de Nīmes 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT06580873
What this trial is testing

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

Who this might be right for
HIV-1-infectionOpioid Use Disorder
Saskatchewan Health Authority - Regina Area 40
Large-scale testing (Phase 3)Study completedNCT00000311
What this trial is testing

Combining Behavioral Treatment With Agonist Maintenance - 1

Who this might be right for
Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Yale University 168
Not applicableStudy completedNCT04104022
What this trial is testing

Prolonged Exposure Therapy for PTSD and Opioid Use Disorder

Who this might be right for
Post Traumatic Stress DisorderOpioid-use Disorder
University of Vermont 82
Testing effectiveness (Phase 2)Study completedNCT00993863
What this trial is testing

Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction

Who this might be right for
Acute Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 201
Testing effectiveness (Phase 2)Looking for participantsNCT05529927
What this trial is testing

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Who this might be right for
Cocaine Use Disorder
Parnassia Addiction Research Centre 204
Not applicableStudy completedNCT07569211
What this trial is testing

Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine

Who this might be right for
HCVOpioid Use Disorder
Ukrainian Institute on Public Health Policy 616
Testing effectiveness (Phase 2)Study completedNCT04199728
What this trial is testing

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Who this might be right for
Opiate Substitution TreatmentOpioid-Related Disorders
Milton S. Hershey Medical Center 27
Post-approval studies (Phase 4)Study completedNCT03033732
What this trial is testing

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse

Who this might be right for
Opioid Use Disorder
Didier Jutras Aswad 272
Post-approval studies (Phase 4)Looking for participantsNCT07439549
What this trial is testing

Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial

Who this might be right for
Opioid Use Disorder
Pouya Azar 12
Testing effectiveness (Phase 2)Looking for participantsNCT04234191
What this trial is testing

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
University of British Columbia 50
Post-approval studies (Phase 4)Looking for participantsNCT07160075
What this trial is testing

HIV Prevention With PrEP Among People on Opioid Replacement Therapy

Who this might be right for
HIV - Human Immunodeficiency Virus
Cara Spence 350
Not applicableStudy completedNCT05242848
What this trial is testing

Integrated Exercise Program in Opioid Agonist Therapy Clinics

Who this might be right for
Substance-Related Disorders
Haukeland University Hospital 309
Large-scale testing (Phase 3)Study completedNCT01908842
What this trial is testing

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults

Who this might be right for
Opioid Dependence, on Agonist Therapy
Orexo AB 759
Not applicableStudy completedNCT01592461
What this trial is testing

Starting Treatment With Agonist Replacement Therapies Follow-up Study

Who this might be right for
Opioid Dependence
University of California, Los Angeles 877
Post-approval studies (Phase 4)Not Yet RecruitingNCT07546396
What this trial is testing

Methadone Rapid Restart

Who this might be right for
Opioid Use Disorder
Pouya Azar 25
Not applicableStudy completedNCT04049799
What this trial is testing

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions

Who this might be right for
Opioid-use DisorderOpioid WithdrawalNeonatal Abstinence Syndrome+1 more
University of Vermont 88
Load More Results